Elisa Gotti

Bergamo, 24122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.

Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.

Journal: Journal of translational medicine

Published: January 18, 2025

Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.

Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.

Journal: Blood cancer journal

Published: January 08, 2025

Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab.

Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab.

Journal: Antibodies (Basel, Switzerland)

Published: May 24, 2024

Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL.

Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL.

Journal: Blood cancer journal

Published: February 24, 2024

Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use.

Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use.

Journal: Cytotherapy

Published: August 06, 2021

Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors.

Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors.

Journal: Cytotherapy

Published: December 15, 2017

Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance.

Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance.

Journal: Cytotherapy

Published: September 14, 2017

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: May 23, 2017

Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey.

Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey.

Journal: Cytotherapy

Published: May 17, 2013

Ofatumumab is more efficient than rituximab in lysing B chronic lymphocytic leukemia cells in whole blood and in combination with chemotherapy.

Ofatumumab is more efficient than rituximab in lysing B chronic lymphocytic leukemia cells in whole blood and in combination with chemotherapy.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 11, 2012

Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells.

Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells.

Journal: Stem cells and development

Published: October 23, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026